tm
Seeing Is Believing
tm
Seeing Is Believing
AKRO is currently covered by 1 analysts
Akero Therapeutics's activity chart (see below) currently has 105 price targets and 87 ratings on display. The stock rating distribution of AKRO is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 45.31% with an average time for these price targets to be met of 216.43 days.
Most recent stock forecast was given by PRAKHAR AGRAWAL from CANTOR FITZGERALD on 10-Dec-2025. First documented stock forecast 15-Jul-2019.
Currently out of the existing stock ratings of AKRO, 1 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 19-Sep-2023
10 months 15 days ago
(10-Dec-2025)
0/4 (0%)
$29.93 (96.33%)
Buy Since 04-Sep-2025
$54
$-0.65 (-1.19%)
$72
1 years 15 days ago
(10-Oct-2025)
2/7 (28.57%)
$0.12 (0.22%)
70
Buy Since 10-Feb-2020
$54
$-0.65 (-1.19%)
$56
1 years 16 days ago
(09-Oct-2025)
7/10 (70%)
$-0.08 (-0.15%)
356
Buy Since 19-Dec-2022
$84
$29.35 (53.71%)
$84
1 years 2 months 19 days ago
(06-Aug-2025)
1/7 (14.29%)
$31.21 (59.12%)
329
Buy Since 04-Aug-2025
$76
$21.35 (39.07%)
1 years 2 months 21 days ago
(04-Aug-2025)
0/1 (0%)
$27.38 (56.31%)
What is AKRO (Akero Therapeutics) average time for price targets to be met?
Which analyst most recently updated their price target on AKRO (Akero Therapeutics)?
Which analyst has the most public recommendations on AKRO (Akero Therapeutics)?
Which analyst is the currently most bullish on AKRO (Akero Therapeutics)?
Which analyst is the currently most reserved on AKRO (Akero Therapeutics)?
